Foxp3 Expressing CD4+ CD25+ and CD8+CD28− T Regulatory Cells in the Peripheral Blood of Patients with Lung Cancer and Pleural Mesothelioma

Meloni, Federica, Morosini, Monica, Solari, Nadia, Passadore, Ileana, Nascimbene, Caterina, Novo, Monique, Ferrari, Marco, Cosentino, Marco, Marino, Franca, Pozzi, Ernesto, Fietta, Anna M.·2006·Human Immunology
DOI 10.1016/j.humimm.2005.11.005

Cited by (169)

Items 101–169 of 169

  1. Accumulation of CD28null Senescent T-Cells Is Associated with Poorer Outcomes in COVID19 Patients
    Mia J. Coleman, Kourtney M. Zimmerly, Xuexian O. Yang · 2021 · Biomolecules
  2. Deep phenotyping of T cell populations under long‐term treatment of tacrolimus and rapamycin in patients receiving renal transplantations by mass cytometry
    Yiyang Li, Huimin An, Chuan Shen, Boqian Wang, Ting Zhang, Yifan Hong, Hui Jiang, Peijun Zhou, Xianting Ding · 2021 · Clinical and Translational Medicine
  3. Na+/H+ exchanger regulatory factor 1 expression levels in blood and tissue predict breast tumour clinical behaviour
    Antonia Bellizzi, Anita Mangia, Andrea Malfettone, Rosa Angela Cardone, Giovanni Simone, Stephan J. Reshkin, Angelo Paradiso · 2011 · Histopathology
  4. LAP TGF-Beta Subset of CD4+CD25+CD127−Treg Cells is Increased and Overexpresses LAP TGF-Beta in Lung Adenocarcinoma Patients
    Lorenzo Islas-Vázquez, Heriberto Prado-Garcı́a, Dolores Aguilar‐Cázares, Manuel Meneses-Flores, Miriam Galicia-Velasco, Susana Romero‐Garcia, Catalina Camacho-Mendoza, José Sullivan López-González · 2015 · BioMed Research International
  5. CD8+ regulatory T cells—A distinct T-cell lineage or a transient T-cell phenotype?
    Einar Martin Aandahl, Knut Martin Torgersen, Kjetil Taskén · 2008 · Human Immunology
  6. Predictors of Immunosuppressive Regulatory T Lymphocytes in Healthy Women
    Shalaka S. Hampras, Mary Nesline, Paul K. Wallace, Kunle O. Odunsi, Nicholas Furlani, Warren Davis, Kirsten B. Moysich · 2012 · Journal of Cancer Epidemiology
  7. Tumour infiltrating lymphocytes and PD-L1 expression as potential predictors of outcome in patients with malignant pleural mesothelioma
    Navid Sobhani, Giandomenico Roviello, Tania Pivetta, Anna Ianza, Deborah Bonazza, Fabrizio Zanconati, Fabiola Giudici, Cristina Bottin, Silvia Paola Corona, A. Guglielmi et al. · 2019 · Molecular Biology Reports
  8. Locally Advanced Lung Cancer
    Puneeth Iyengar, David E. Gerber · 2013 · The Cancer Journal
  9. Lenalidomide overcomes the immunosuppression of regulatory CD8+CD28− T-cells
    Brigitte Neuber, Jingying Dai, Wjahat A. Waraich, Mohamed H.S. Awwad, Mélanie Engelhardt, Michael W. Schmitt, Sergej Medenhoff, Mathias Witzens‐Harig, Anthony Dick Ho, Hartmut Goldschmidt et al. · 2017 · Oncotarget
  10. Fungi, immunosenescence and cancer
    Bin Xu, Zan Luo, Xing Niu, Zhi Li, Yeping Lu, Junyu Li · 2025 · Seminars in Cancer Biology
  11. The Role of Regulatory T Cells in Mesothelioma
    Demelza J. Ireland, Haydn Thomas Kissick, Manfred W. Beilharz · 2012 · Cancer Microenvironment
  12. Regulatory T Cells in children with intestinal parasite infection
    Mariana Haydee García-Hernández, Brenda Alvarado‐Sánchez, Miriam Z. Calvo‐Turrubiartes, Mariana Salgado‐Bustamante, C. Y. RODRÍGUEZ‐PINAL, L. R. GÁMEZ‐LÓPEZ, Roberto González‐Amaro, Diana Patricia Portales‐Pérez · 2009 · Parasite Immunology
  13. Increased expression of Foxp3 in splenic CD8+ T cells from mice with anterior chamber-associated immune deviation.
    Liqiong Jiang, Peizeng Yang, Hao He, Bing Li, Xiaomin Lin, Shengping Hou, Hongyan Zhou, Xiangkun Huang, Aize Kijlstra · 2007 · PubMed Central
  14. Myeloid cells meet CD8+ T cell exhaustion in cancer: What, why and how
    Yijie Zhai, Xiaoting Liang, Mi Deng · 2024 · Chinese Journal of Cancer Research
  15. Immunotherapy in malignant peritoneal mesothelioma (Review)
    Sabah Alaklabi, Arya Mariam Roy, Joseph J. Skitzki, Renuka V. Iyer · 2023 · Molecular and Clinical Oncology
  16. Characteristics and mechanisms of T‐cell senescence: A potential target for cancer immunotherapy
    Han Wu, Junru Li, Zhen Zhang, Yi Zhang · 2024 · European Journal of Immunology
  17. Targeting the Immune System in the Treatment of Non-Small-Cell Lung Cancer
    D. Rangachari, J. Brahmer · 2013 · Current Treatment Options in Oncology
  18. Newly Found Peacekeeper: Potential of CD8+ Tregs for Graft-Versus-Host Disease
    Weihao Wang, Tao Hong, Xiaoqi Wang, Rui Wang, Yuxuan Du, Qiangguo Gao, Shijie Yang, Xi Zhang · 2021 · Frontiers in Immunology
  19. Leprosy as a model to understand cancer immunosurveillance and T cell anergy
    Andrew J Park, Tina Rendini, Frank T. Martiniuk, William R. Levis · 2016 · Journal of Leukocyte Biology
  20. ANALYSIS OF CD8+CD28−T-SUPPRESSOR CELLS IN GASTRIC CANCER PATIENTS
    Yu Shen, Qiu‐Xia Qu, Yibei Zhu, Xueguang Zhang · 2012 · Journal of Immunoassay and Immunochemistry
  21. The Road to Memory: An Early Rest for the Long Journey
    Liam Pock Ho, Pui San Yit, Lee Hui Ng, Yeh Ching Linn, Yi Zhao, Li Jun Sun, Khoon Lin Ling, Mickey Koh, Meng-Chun Monica Shih, Shang Li et al. · 2013 · The Journal of Immunology
  22. Gene expression profiling of CD 8+ T cells induced by ovarian cancer cells suggests a possible mechanism for CD 8+ Treg cell production
    Meng Chao Wu, Jianfang Lou, Shuping Zhang, Xian Chen, Lei Huang, Ruihong Sun, Peijun Huang, Shiyang Pan, Fang Wang · 2016 · Cell Proliferation
  23. Human Peripheral Blood CD8+ CD28− T Cells of Renal Allograft Recipients Do Not Express FOXP3 Protein
    A Korecka, A Duszota, Piotr Wierzbicki, Mariusz Niemczyk, Katarzyna Bocian, Danuta Kłosowska, Leszek Pączek, Andrzej Górski, G Korczak-Kowalska · 2011 · Transplantation Proceedings
  24. Circulating and Tumor-Infiltrating Foxp3+ Regulatory T Cell Subset in Chinese Patients with Extranodal NK/T Cell Lymphoma
    Roujun Peng, Zhou-Feng Huang, Yi-Lan Zhang, Zhong-Yu Yuan, Yi Xia, Wen-Qi Jiang, Yi-Xin Zeng, Jiang Li · 2011 · International Journal of Biological Sciences
  25. SUBPOPULATION COMPOSITION OF PERIPHERAL BLOOD LYMPHOCYTES IN UVEAL MELANOMA
    Svetlana Vladimirovna Saakyan, Natalya Vladimirovna Balatskaya, Л. А. Катаргина, I. G. Kulikova, Elena Borisovna Myakoshina · 2019 · Medical Immunology (Russia)
  26. CD28 engagement inhibits CD73-mediated regulatory activity of CD8+ T cells
    Yo‐Ping Lai, Lu-Cheng Kuo, Been‐Ren Lin, Hung‐Ju Lin, Chih-Yu Lin, Yi‐Ting Chen, Pei‐Wen Hsiao, Huan‐Tsung Chang, Patrick Chow‐In Ko, Hsiao-Chin Chen et al. · 2021 · Communications Biology
  27. Immunotherapy for recurrent ovarian cancer: a further piece of the puzzle or a striking strategy?
    Giuseppe Bronte, Giuseppe Cicero, Giovanni Sortino, Gianfranco Pernice, Maria Teresa Catarella, Paolo D'Alia, Stefania Cusenza, Silvia Lo Dico, Enrico Bronte, Delia Sprini et al. · 2013 · Expert Opinion on Biological Therapy
  28. Human CD8+CD28− T suppressor cells expanded by common gamma chain (γc) cytokines retain steady allospecific suppressive capacity in vivo
    Guihuan Liu, Yuming Yu, Fu Feng, Ping Zhu, Hua Zhang, Danni Zhang, Xiaoqiang Feng, Zedan Zhang, Yanjun Liu · 2020 · BMC Immunology
  29. A validated nomogram integrating baseline peripheral T-lymphocyte subsets and NK cells for predicting survival in stage I–IIIA non-small cell lung cancer after resection
    Lili Xu, Yingbin Luo, Jianhui Tian, Zhihong Fang, Weikang Zhu, Bo Zhang, Jianchun Wu, Yan Li · 2022 · Annals of Translational Medicine
  30. Tumour eradication and induction of memory against murine mesothelioma by combined immunotherapy
    Haydn Thomas Kissick, Demelza J. Ireland, Shruti Krishnan, Mutsa Madondo, Manfred W. Beilharz · 2012 · Immunology and Cell Biology
  31. New capabilities of regulation of antitumor immune response
    Кадагидзе Заира Григорьевна, Черткова Антонина Ивановна, Т. Н. Заботина, Короткова Ольга Витальевна, E. G. Slavina, Борунова Анна Анатольевна · 2015 · Malignant tumours
  32. Therapeutic effects of mucosal tolerance on experimental colitis in rats
    Shanshan Zhang, Liu Yulan · 2009 · European Journal of Gastroenterology & Hepatology
  33. Clinical immunology CD4+CD25high, CD8+CD28– cells and thyroid autoantibodies in breast cancer patients
    Oğuz Bilgi, Bülent Karagöz, Orhan Türken, Mustafa Gültepe, Alpaslan Özgün, Tolga Tunçel, Levent Emi̇rzeoglu, Serkan Èçelik, Tuba Müftüoğlu, Emin Gökhan Kandemir · 2014 · Central European Journal of Immunology
  34. Depletion of Treg Cells Augments the Therapeutic Effect of Cancer Vaccines
    Jan Bubeník · 2006 · Folia Biologica
  35. Comparison of circulating immune signatures across different consensus molecular subtypes (CMS) and between left- and right-sided lesions in stage II colorectal cancer using single-cell mass cytometry
    Pin Gao, Chuanyong Zhou, Hong Yang, Shunyu Deng, Beihai Jiang, Zaozao Wang, Jiabo Di, Xiangqian Su · 2025 · Journal of Translational Medicine
  36. Engineering immune response to regulate cardiovascular disease and cancer
    Diksha Rani, Smaranjot Kaur, Shahjahan, Joy Kumar Dey, Sanjay Kumar Dey · 2024 · Advances in protein chemistry and structural biology
  37. Cancer risk in HIV-infected patients
    Isabelle Poizot‐Martin, Hélène Laroche, Carla Eliana Cano, Corinne Nicolino‐Brunet, Olivia Zaegel‐Faucher, Sylvie Brégigeon, Catherine Tamalet, Françoise Dignat‐George · 2018 · AIDS
  38. Circulating T regulatory cell subsets in patients with untreated lung cancer
    Dahiana Amarillo, Andreína Brugnini, Natalia Trías, Virginia Rodríguez Sande, Siul Salisbury, Mauricio Cuello, Daniela Lens · 2022 · Clinical & Translational Oncology
  39. Stress and Immune System Aging
    Rita B. Effros · 2012 · Oxford University Press eBooks
  40. Advances in systemic therapy for malignant mesothelioma: future perspectives
    Navid Sobhani, Silvia Paola Corona, Deborah Bonazza, Anna Ianza, Tania Pivetta, Giandomenico Roviello, Maurizio Cortale, Alessandra Guglielmi, Fabrizio Zanconati, Daniele Generali · 2017 · Future Oncology
  41. Statins, regulatory T cells, and pediatric graft coronary artery disease
    Mark R. Goldstein, Luca Mascitelli, Francesca Pezzetta · 2008 · Pediatric Transplantation
  42. T Cell Senescence and Tumor Immunotherapy
    Xia Liu, Guangyong Peng · 2018 · Springer eBooks
  43. Multi-omics integration reveals CYTL1 and H6PD as key regulators of tumor metabolism in mesothelioma
    Jiao Ma, Huilin Zhang, Liang Yu, Yunqing Guo, Jiawei Ming, Zhenying Guo · 2025 · Genes & Genomics
  44. The Role of T-regulatory Cells in Immune Senescence
    Paul A. H. Moss · 2009 · Springer eBooks
  45. T Cell Senescence and Tumor Immunotherapy
    Xia Liu, Guangyong Peng · 2019 · Springer eBooks
  46. Role of Cytomegalovirus in Driving Cytotoxic CD28null T Cells
    Alejandra Pera, Aalia Bano, Florian Kern · 2019 · Springer eBooks
  47. CD28neg. T lymphocytes of a melanoma patient harbor tumor immunity and a high frequency of germline-encoded and public TCRs
    Hisayoshi Hashimoto, Marco Sterk, Karin Schilbach · 2017 · Immunologic Research
  48. Relationship Between Th17 and Regulatory T Cells in the Tumor Environment
    Ilona Kryczek, Ke Wu, Ende Zhao, Guobin Wang, Weiping Zou · 2011 · Springer eBooks
  49. The Role of Immunotherapy in the Treatment of Mesothelioma
    Saly Al‐Taei, F. Jason, Zsuzsanna Tabi · 2012 · InTech eBooks
  50. Decrease of peripheral blood CD8+/CD28-suppressor T cell followed by dentritic cells immunomodulation among metastatic breast cancer patients
    Guohong Song, Jun Ren, Lijun Di, Jing Yu, Jie Zhang, Bin Shao, Jun Jia, Wei Sun · 2010 · Chinese Journal of Cancer Research
  51. Aging, Nutrient Signaling, Hematopoietic Senescence, and Cancer
    Priya Balasubramanian, Valter Daniel Longo · 2013 · Critical Reviews™ in Oncogenesis
  52. Department of Cardiothoracic Surgery,Changzheng Hospital,Second Military Medical University,Shanghai 200003,China
    Lei Xue, Zhifei Xu · 2009 · Academic Journal of Second Military Medical University
  53. Regulatory T Cells and Tumour Immunotherapy
    Ilona Kryczek, Weiping Zou · 2008 · Springer eBooks
  54. T Cell Fate in the Tumor Microenvironment
    Joel Crespo, Ilona Kryczek, Theodore Hobart Welling, Shuang Wei, Weiping Zou · 2015 · Cancer drug discovery and develogment/Cancer drug discovery and development
  55. CD8+FoxP3+ T cells: A new player in the immune response to ovarian cancer
    Sara E. F. Kost · 2013 · UVic’s Research and Learning Repository (University of Victoria)
  56. EVALUATION OF T- REGULATORY CELLS IN BREAST CANCER.
    Ola Sayed M. Ali, MahaA.El Taweel, ImanAttiaAbdelEl Gawad, EmanAhmed Gouda. · 2017 · International Journal of Advanced Research
  57. LYMPHOCYTE SUBSETS IN PERIPHERAL BLOOD OF HER2-POSITIVE AND TRIPLE NEGATIVE BREAST CANCER PATIENTS
    Черткова Антонина Ивановна, Славина Елена Григорьевна, Lyudmila Zhukova, Ганьшина Инна Петровна, M. F. Okruzhnova, Шоуа Эсма Константиновна, V. A. Nurtdinova, Борунова Анна Анатольевна, Кадагидзе Заира Григорьевна · 2015 · Russian Journal of Biotherapy
  58. Role of Cytomegalovirus in Driving Cytotoxic CD28null T Cells
    Alejandra Pera, Aalia Bano, Florian Kern · 2018 · Springer eBooks
  59. Dynamic Biomarkers Indicate Immunological Benefits Provided by Ganoderma Spore Powder in Post-Operative Breast and Lung Cancer Patients: A Prospective Clinical Trial
    Yuwei Deng, Jianli Ma, Dabei Tang, Qingyuan Zhang · 2020
  60. Papel dos neutrófilos e células T CD8 na infecção por Zika vírus
    Nágela Ghabdan Zanluqui · 2021 · Digital Library of Theses and Dissertations (Universidade de São Paulo)
  61. The Role of T Regulatory Cells in Immune Senescence
    Paul A. H. Moss · 2019 · Springer eBooks
  62. The Role of T Regulatory Cells in Immune Senescence
    Paul A. H. Moss · 2018 · Springer eBooks
  63. Nivolumab in the treatment of thoracic cancer — new possibilities
    Magdalena Knetki‐Wróblewska, Kamila Wojas‐Krawczyk · 2022 · Oncology in Clinical Practice
  64. Persistence of peripheral CD8 + CD28− T cells indicates a favourable outcome and tumour immunity in first-line HER2-positive metastatic breast cancer
    Xiaoran Liu, Xiangming Cheng, Feng Xie, Kun Li, Yongcan Shi, Bin Shao, Liang Xu, Wan Fengling, Shidong Jia, Yue Zhang et al. · 2024 · British Journal of Cancer
  65. Evaluating the Efficacy of Immune Checkpoint Inhibitors in Elderly Patients: A Systematic Review and Meta-analysis
    Han Sang Kim · 2024 · Methods in molecular biology
  66. Rôle des lymphocytes T Résidents Mémoires (TRM) et des intégrines CD103 et CD49a dans la réponse aux immunothérapies ciblant PD-1 et CTLA-4
    Isabelle Damei · 2022 · theses.fr (ABES)
  67. Single cell multi-OMICS analysis of Treg biology in cancer
    Wilfrid Richer · 2021 · theses.fr (ABES)
  68. Modulation de l'activation des lymphocytes T et des réponses anti-tumorales par le fer
    Sarah Porte · 2022 · theses.fr (ABES)
  69. Immune tolerance: Parallels between pregnancy and kidney transplantation.
    Suraksha Agrawal · 2026 · Human Immunology